The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
Intense research over the past four years has led to the discovery and characterization of a novel signalling network, known as the Salvador-Warts-Hippo (SWH) pathway, involved in tissue growth control in Drosophila melanogaster. At present, eleven proteins have been implicated as members of this pathway, and several downstream effector genes have been characterized. The importance of this pathway is emphasized by its evolutionary conservation, and by increasing evidence that its deregulation occurs in human tumours. Here, we review the main findings from Drosophila and the implications that these have for tumorigenesis in mammals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B., & Cohen, S. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00231-9 · Cited by 2,042
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
A Protein Interaction Map of Drosophila melanogaster
Giot, L., Bader, J. S., Brouwer, C., Chaudhuri, A., Kuang, B., Li, Y., Hao, Y. L., Ooi, C. E., Godwin, B., Vitols, E., et al. (2003) · Science · doi:10.1126/science.1090289 · Cited by 1,863 · cited 1×
“In unbiased protein–protein interaction screens in both Drosophila and mammals, YKI and YAP, and SD and TEF proteins were identified as binding partner”
BackgroundERM proteins and merlin: integrators at the cell cortex
Bretscher, A., Edwards, K., & Fehon, R. G. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm882 · Cited by 1,306
A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors
Voorhoeve, P. M., le Sage, C., Schrier, M., Gillis, A. J. M., Stoop, H., Nagel, R., Liu, Y.-P., van Duijse, J., Drost, J., Griekspoor, A., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.037 · Cited by 1,264
Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Justice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes & Development · doi:10.1101/gad.9.5.534 · Cited by 977
Research works printed but not linked: 1
- Polesello, C., Huelsmann, S., Brown, N. H. & Tapon, N. The Drosophila RASSF homologue antagnosis the Hippo pathway. Curr. Biol. 16, 2459–2465 (2006). · DOI · Paper page
Cited by
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
“In addition, mutations of Lats1/2, Sav, and Mob have been implicated in tumorigenesis (St John et al. 1999; Tapon et al. 2002; Lai et al. 2005; Takahashi et al. 2005; Harvey and Tapon 2007).”
BackgroundTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
“Recent genetic studies in Drosophila have identified a novel tumor suppressor pathway, the Hippo pathway (Harvey et al. 2003; Wu et al. 2003; Lai et al. 2005; Edgar 2006; Hariharan and Bilder 2006; Harvey and Tapon 2007).”
BackgroundThe Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3458 · Cited by 1,842
Self-citationMechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667
MicroRNA control of signal transduction
Inui, M., Martello, G., & Piccolo, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2868 · Cited by 1,272
“The core protein engines of developmental signalling networks are highly conserved devices, which can be traced back to the common ancestor of all Bilateri”
BackgroundYap1 acts downstream of α-catenin to control epidermal proliferation
Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.031 · Cited by 1,036
“It has been speculated that this pathway could be involved in interpreting morphogen gradients to regulate tissue size, and therefore the existence of a secreted or membrane ligand has been postulated (Harvey and Tapon, 2007).”
Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP
Hao, Y., Chun, A., Cheung, K., Rashidi, B., & Yang, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709037200 · Cited by 786
Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration
Jopling, C., Boue, S., & Belmonte, J. C. I. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3043 · Cited by 730
“melanogaster with inactive forms of both RB and Hippo (a member of the STE20 family of protein kinases”
BackgroundHippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Lu, L., Li, Y., Kim, S. M., Bossuyt, W., Liu, P., Qiu, Q., Wang, Y., Halder, G., Finegold, M. J., Lee, J.-S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911427107 · Cited by 721
Involvement of Members of the Cadherin Superfamily in Cancer
Berx, G., & van Roy, F. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003129 · Cited by 709
“In the fly, Fat modulates cell contact inhibition and organ size by functioning upstream of the (Hippo/Salvador)-(Warts/Mats)-YorkieScalloped signaling pathway (reviewed in Harvey and Tapon 2007; Zeng and Hong 2008; Zhao et al. 2008).”
BackgroundWu, S., Liu, Y., Zheng, Y., Dong, J., & Pan, D. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.007 · Cited by 640
“Studies in recent years, primarily conducted in the fruit fly Drosophila, have implicated the Hippo (Hpo) signaling pathway as a central mechanism that regulates organ size by controlling both cell proliferation and cell death (Edgar, 2006; Pan, 2007; Harvey and Tapon, 2007).”
BackgroundA Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Jiao, S., Wang, H., Shi, Z., Dong, A., Zhang, W., Song, X., He, F., Wang, Y., Zhang, Z., Wang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.010 · Cited by 602
“The Hippo pathway controls multiple cellular processes related to cell proliferation and apoptosis and its dysregulation has been linked to various cancers (Chan et al., 2011; Harvey and Tapon, 2007; Pan, 2010; Steinhardt et al., 2008; Zhao et al., 2010).”
BackgroundMorrison, D. K. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.10.003 · Cited by 605
“The mammalian Hippo pathway also contributes to organ size control [51,52] and dysregulation of numerous Hippo pathway components, including Mer, Sav, Lats and YAP, has been observed in human tumors [48,53].”
BackgroundMammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Song, H., Mak, K. K., Topol, L., Yun, K., Hu, J., Garrett, L., Chen, Y., Park, O., Chang, J., Simpson, R. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911409107 · Cited by 583
Epithelial cell polarity, stem cells and cancer
Martin-Belmonte, F., & Perez-Moreno, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3169 · Cited by 552
“that regulate tissue growth by promoting cell cycle exit and apoptosi”
BackgroundLiu, C.-Y., Zha, Z.-Y., Zhou, X., Zhang, H., Huang, W., Zhao, D., Li, T., Chan, S. W., Lim, C. J., Hong, W., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152942 · Cited by 525
Yin, F., Yu, J., Zheng, Y., Chen, Q., Zhang, N., & Pan, D. (2013) · Cell · doi:10.1016/j.cell.2013.08.025 · Cited by 504
“…comprehensive survey of Hippo pathway components showed that like Merlin, Sav/Sav1, a scaffold protein that has been reported to bind Wts/Lats and Hpo/Mst (Harvey and Tapon, 2007), is localized almost exclusively in the membrane fraction in both Drosophila and mammalian cells (Figures S6A and S6B).”
BackgroundInfluentialMst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2
Maejima, Y., Kyoi, S., Zhai, P., Liu, T., Li, H., Ivessa, A., Sciarretta, S., Del Re, D. P., Zablocki, D. K., Hsu, C.-P., et al. (2013) · Nature Medicine · doi:10.1038/nm.3322 · Cited by 499
Molecular evolution of the cadherin superfamily
Hulpiau, P., & van Roy, F. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.09.027 · Cited by 498
“So in Drosophila, Fat but not Ds was ound to act as upstream receptor of the SWH (Salvador-Wartsippo) pathway, which has several links with human oncogenesis reviewed by Harvey and Tapon, 2007).”
BackgroundThe Hippo–YAP pathway: new connections between regulation of organ size and cancer
Zhao, B., Lei, Q.-Y., & Guan, K.-L. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.10.001 · Cited by 455
Donninger, H., Vos, M. D., & Clark, G. J. (2007) · Journal of Cell Science · doi:10.1242/jcs.010389 · Cited by 440
“This pathway involves the coupling of MST kinases to the LATs kinases via an adaptor protein called Salvador that acts as a tumor suppressor in Drosophila (Harvey and Tapon, 2007).”
BackgroundInfluentialZeng, Q., & Hong, W. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.011 · Cited by 435
“Wts/LatsMats/Mob1 is activated by Hippo/Mst-mediated phosphorylation.”
BackgroundInfluentialCouzens, A. L., Knight, J. D. R., Kean, M. J., Teo, G., Weiss, A., Dunham, W. H., Lin, Z.-Y., Bagshaw, R. D., Sicheri, F., Pawson, T., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004712 · Cited by 441
“The Hippo pathway was first characterized in Drosophila melanogaster, in which genetic inhibition of pathway components leads to cellular overgrowth reminiscent of tumor hyperplasia (1, 2).”
BackgroundZhang, J., Ji, J.-Y., Yu, M., Overholtzer, M., Smolen, G. A., Wang, R., Brugge, J. S., Dyson, N. J., & Haber, D. A. (2009) · Nature Cell Biology · doi:10.1038/ncb1993 · Cited by 424
MOBKL1A/MOBKL1B Phosphorylation by MST1 and MST2 Inhibits Cell Proliferation
Praskova, M., Xia, F., & Avruch, J. (2008) · Current Biology · doi:10.1016/j.cub.2008.02.006 · Cited by 422
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
Calses, P. C., Crawford, J. J., Lill, J. R., & Dey, A. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.04.001 · Cited by 420
Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Gene
Shen, C., Beroukhim, R., Schumacher, S. E., Zhou, J., Chang, M., Signoretti, S., & Kaelin, W. G. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0098 · Cited by 413
Kibra Is a Regulator of the Salvador/Warts/Hippo Signaling Network
Genevet, A., Wehr, M. C., Brain, R., Thompson, B. J., & Tapon, N. (2010) · Developmental Cell · doi:10.1016/j.devcel.2009.12.011 · Cited by 402
“Kibra Regulates SWH Network Targets in Ovarian Posterior Follicle Cells Several transcriptional targets of the SWH network have been identified, such as the Drosophila Inhibitor of Apoptosis 1 (DIAP1) gene, the cell cycle regulator cycE, the miRNA bantam, as well as ex (Harvey and Tapon, 2007; Saucedo and Edgar, 2007).”
BackgroundSelf-citationOta, M., & Sasaki, H. (2008) · Development · doi:10.1242/dev.027151 · Cited by 391
“Genetic screening in Drosophila has identified the Hippo signaling pathway as a key mechanism of organ size control (for reviews, see Harvey and Tapon, 2007; Pan, 2007; Reddy and Irvine, 2008; Saucedo and Edgar, 2007).”
BackgroundA molecular mechanism that links Hippo signalling to the inhibition of Wnt/β‐catenin signalling
Imajo, M., Miyatake, K., Iimura, A., Miyamoto, A., & Nishida, E. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.487 · Cited by 378
“Previous studies reported that the Hippo pathway is often inactivated in a number of cancers (Harvey and Tapon, 2007; Pan, 2010; Zhao et al , 2010; Halder and Johnson, 2011).”
InfluentialMst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)
Oka, T., Mazack, V., & Sudol, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804380200 · Cited by 367
Saucedo, L. J., & Edgar, B. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2221 · Cited by 363
Zhang, W., Nandakumar, N., Shi, Y., Manzano, M., Smith, A., Graham, G., Gupta, S., Vietsch, E. E., Laughlin, S. Z., Wadhwa, M., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005049 · Cited by 360
Lgl, aPKC, and Crumbs Regulate the Salvador/Warts/Hippo Pathway through Two Distinct Mechanisms
Grzeschik, N. A., Parsons, L. M., Allott, M. L., Harvey, K. F., & Richardson, H. E. (2010) · Current Biology · doi:10.1016/j.cub.2010.01.055 · Cited by 346
“SWH targets include the cell proliferation regulator cyclin E (cycE) and Drosophila inhibitor of apoptosis 1 (DIAP1), which promote tissue growth and survival, respectively [1, 2, 7, 8].”
InfluentialSelf-citationThe WW Domain Protein Kibra Acts Upstream of Hippo in Drosophila
Baumgartner, R., Poernbacher, I., Buser, N., Hafen, E., & Stocker, H. (2010) · Developmental Cell · doi:10.1016/j.devcel.2009.12.013 · Cited by 320
DeRan, M., Yang, J., Shen, C.-H., Peters, E. C., Fitamant, J., Chan, P., Hsieh, M., Zhu, S., Asara, J. M., Zheng, B., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.036 · Cited by 316
“Nuclear YAP/TAZ bind to C TEA domain transcription factors (TEAD); promote the expression of target genes; and modulate diverse cellular functions, including proliferation, apoptosis, migration, and differentiation (Harvey et al., 2013; Hong and Guan, 2012).”
InfluentialWang, Z., Wu, Y., Wang, H., Zhang, Y., Mei, L., Fang, X., Zhang, X., Zhang, F., Chen, H., Liu, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319190110 · Cited by 316
Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module
Humbert, P. O., Grzeschik, N. A., Brumby, A. M., Galea, R., Elsum, I., & Richardson, H. E. (2008) · Oncogene · doi:10.1038/onc.2008.341 · Cited by 318
“The Salvador/ Warts/Hippo (SWH) pathway is a newly described pathway in organ size control and cancer (Harvey and Tapon, 2007; Zeng and Hong, 2008).”
Crumbs Regulates Salvador/Warts/Hippo Signaling in Drosophila via the FERM-Domain Protein Expanded
Robinson, B. S., Huang, J., Hong, Y., & Moberg, K. H. (2010) · Current Biology · doi:10.1016/j.cub.2010.03.019 · Cited by 312
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
Zhang, X., George, J., Deb, S., Degoutin, J. L., Takano, E. A., Fox, S. B., AOCS Study group, Bowtell, D. D. L., & Harvey, K. F. (2011) · Oncogene · doi:10.1038/onc.2011.8 · Cited by 309
Self-citationShaw, R. L., Kohlmaier, A., Polesello, C., Veelken, C., Edgar, B. A., & Tapon, N. (2010) · Development · doi:10.1242/dev.052506 · Cited by 307
“The highly conserved Salvador/Warts/Hippo signalling pathway is a key regulator of organ size (Harvey and Tapon, 2007).”
BackgroundSelf-citationThe apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila
Chen, C.-L., Gajewski, K. M., Hamaratoglu, F., Bossuyt, W., Sansores-Garcia, L., Tao, C., & Halder, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004060107 · Cited by 302
The RASSF proteins in cancer; from epigenetic silencing to functional characterization
Richter, A. M., Pfeifer, G. P., & Dammann, R. H. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.004 · Cited by 295
“Taken together Hpo activates Wts via phosphorylation and Sav serves as a scaffold for these two [119,120].”
BackgroundYap- and Cdc42-Dependent Nephrogenesis and Morphogenesis during Mouse Kidney Development
Reginensi, A., Scott, R. P., Gregorieff, A., Bagherie-Lachidan, M., Chung, C., Lim, D.-S., Pawson, T., Wrana, J., & McNeill, H. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003380 · Cited by 293
“Loss of Hippo signaling leads to unrestricted proliferation in flies and mammals, and has been linked to a variety of cancers (reviewed in [10], [11]).”
BackgroundKoontz, L. M., Liu-Chittenden, Y., Yin, F., Zheng, Y., Yu, J., Huang, B., Chen, Q., Wu, S., & Pan, D. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.04.021 · Cited by 283
“The Hippo signaling pathway is a conserved regulator of organ size in Drosophila and mammals, and its dysregulation contributes to human cancers (Halder and Johnson, 2011; Harvey and Tapon, 2007; Pan, 2010; Zhao et al., 2010).”
BackgroundDrosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics
Gonzalez, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3461 · Cited by 282
Lim, J. C. W., Chan, T. K., Ng, D. S., Sagineedu, S. R., Stanslas, J., & Wong, W. F. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05633.x · Cited by 268
The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis
Knippschild, U., Krüger, M., Richter, J., Xu, P., GarcÃa-Reyes, B., Peifer, C., Halekotte, J., Bakulev, V., & Bischof, J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00096 · Cited by 272
“LATS1/2-dependent phosphorylation of the transcriptional co-activator Yes-associated protein (YAP) and its paralog Tafazzin (TAZ) then leads to YAP/TAZ inhibition by spatial separation from its nuclear target transcription factors TEAD (TEA domain) and SMAD (SMA/mothers against decapentaplegic) and additionally by pho…”
BackgroundPhosphoproteome Analysis of Drosophila melanogaster Embryos
Zhai, B., Villén, J., Beausoleil, S. A., Mintseris, J., & Gygi, S. P. (2008) · Journal of Proteome Research · doi:10.1021/pr700696a · Cited by 270
Angiomotin-like Proteins Associate with and Negatively Regulate YAP1
Wang, W., Huang, J., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.205401 · Cited by 269
Structural basis of YAP recognition by TEAD4 in the Hippo pathway
Chen, L., Chan, S. W., Zhang, X., Walsh, M., Lim, C. J., Hong, W., & Song, H. (2010) · Genes & Development · doi:10.1101/gad.1865310 · Cited by 249
Identification of Serum-Derived Sphingosine-1-Phosphate as a Small Molecule Regulator of YAP
Miller, E., Yang, J., DeRan, M., Wu, C., Su, A. I., Bonamy, G. M. C., Liu, J., Peters, E. C., & Wu, X. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.005 · Cited by 246
“Enhanced F-actin polymerization induces organ overgrowth in Drosophila through activation of Yorkie (Fernández et al., 2011; SansoresGarcia et al., 2011; Wada et al., 2011).”
InfluentialZhang, J., Smolen, G. A., & Haber, D. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6205 · Cited by 243
“Functional screens in Drosophila have identified a novel signaling pathway that regulates organ size by modulating cell growth, proliferation, and apoptosis ( 1 , 2). Key components of this pathway are two serine/threonine kinases, Hippo and Warts, and the transcriptional coactivator Yorkie.”
BackgroundLi, W., Cooper, J., Zhou, L., Yang, C., Erdjument-Bromage, H., Zagzag, D., Snuderl, M., Ladanyi, M., Hanemann, C. O., Zhou, P., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.001 · Cited by 243
“The final element, Warts/Lats, phosphorylates and inactivates the transcriptional coactivator Yorkie/ YAP, suppressing Scalloped/TEAD-dependent transcription of genes involved in cell survival and proliferation (Hariharan and Bilder, 2006; Harvey and Tapon, 2007; Pan, 2010; Zhao et al., 2010a).”
Toll Receptor-Mediated Hippo Signaling Controls Innate Immunity in Drosophila
Liu, B., Zheng, Y., Yin, F., Yu, J., Silverman, N., & Pan, D. (2016) · Cell · doi:10.1016/j.cell.2015.12.029 · Cited by 249
“The Hippo signaling pathway is a central regulator of organ size in a diverse range of animals, from Drosophila to mammals (Harvey and Tapon, 2007; Johnson and Halder, 2014; Pan, 2010).”
BackgroundTEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation
Chan, S. W., Lim, C. J., Loo, L. S., Chong, Y. F., Huang, C., & Hong, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901568200 · Cited by 239
Ribeiro, P. S., Josué, F., Wepf, A., Wehr, M. C., Rinner, O., Kelly, G., Tapon, N., & Gstaiger, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.08.002 · Cited by 235
“The Hpo pathway controls the final tissue and organ size by both inhibiting cell proliferation and promoting apoptosis (Harvey and Tapon, 2007).”
InfluentialSelf-citationYAP is a candidate oncogene for esophageal squamous cell carcinoma
Muramatsu, T., Imoto, I., Matsui, T., Kozaki, K.-I., Haruki, S., Sudol, M., Shimada, Y., Tsuda, H., Kawano, T., & Inazawa, J. (2011) · Carcinogenesis · doi:10.1093/carcin/bgq254 · Cited by 227
Poon, C. L. C., Lin, J. I., Zhang, X., & Harvey, K. F. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.09.012 · Cited by 227
Self-citationKim, M., Kim, M., Lee, S., Kuninaka, S., Saya, H., Lee, H., Lee, S., & Lim, D. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.102 · Cited by 217
“The Hippo pathway has been implicated as the major negative regulator of YAP (Harvey and Tapon, 2007; Pan, 2010; Sudol and Harvey, 2010; Zhao et al , 2010a; Halder and Johnson, 2011).”
Oka, T., Remue, E., Meerschaert, K., Vanloo, B., Boucherie, C., Gfeller, D., Bader, G. D., Sidhu, S. S., Vandekerckhove, J., Gettemans, J., et al. (2010) · Biochemical Journal · doi:10.1042/bj20100870 · Cited by 216
Identification of Happyhour/MAP4K as Alternative Hpo/Mst-like Kinases in the Hippo Kinase Cascade
Zheng, Y., Wang, W., Liu, B., Deng, H., Uster, E., & Pan, D. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.08.014 · Cited by 219
“The Hippo signaling pathwaywas initially delineated in themodel organism Drosophila as a critical mechanism that restricts the growth of imaginal discs (Halder and Johnson, 2011; Harvey and Tapon, 2007; Pan, 2007).”
Functional aspects of primary cilia in signaling, cell cycle and tumorigenesis
Basten, S. G., & Giles, R. H. (2013) · Cilia · doi:10.1186/2046-2530-2-6 · Cited by 208
“These findings are exciting since the Hippo pathway comprises a number of proteins that act as a tumor suppressor network in the control of organ size and growth control [105].”
BackgroundIs cell competition relevant to cancer?
Moreno, E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2252 · Cited by 202
PTPN14 interacts with and negatively regulates the oncogenic function of YAP
Liu, X., Yang, N., Figel, S. A., Wilson, K. E., Morrison, C. D., Gelman, I. H., & Zhang, J. (2013) · Oncogene · doi:10.1038/onc.2012.147 · Cited by 196
Upstream Regulation of the Hippo Size Control Pathway
Grusche, F. A., Richardson, H. E., & Harvey, K. F. (2010) · Current Biology · doi:10.1016/j.cub.2010.05.023 · Cited by 196
“Several reviews have distilled our current knowledge of core SWH pathway proteins [4,5,20,21].”
Self-citationA crucial role of WW45 in developing epithelial tissues in the mouse
Lee, J., Kim, T., Yang, T., Koo, B., Oh, S., Lee, K., Oh, H., Lee, S., Kong, Y., Kim, J., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.63 · Cited by 194
“in Drosophila, seems to be a key developmental programme in controlling proliferation and apoptosis for proper organ development in Drosophila (Edgar, 2006; Harvey and Tapon, 2007; Pan, 2007; Saucedo and Edgar, 2007).”
BackgroundInfluentialThe TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis
Zhou, Y., Huang, T., Cheng, A., Yu, J., Kang, W., & To, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010138 · Cited by 194
“The main function of the Hippo pathway is to inhibit proliferation and to promote apoptosis, thereby to limit the overgrowth of organs [50].”
Judson, R. N., Tremblay, A. M., Knopp, P., White, R. B., Urcia, R., De Bari, C., Zammit, P. S., Camargo, F. D., & Wackerhage, H. (2012) · Journal of Cell Science · doi:10.1242/jcs.109546 · Cited by 190
“The elements and function of the Hippo pathway were first identified during genetic screens for tumour suppressors in Drosophila melanogaster, where knockout of the inhibitory components upstream of the Yap homologue Yorkie resulted in overgrowth phenotypes (Harvey and Tapon, 2007).”
BackgroundKIBRA Regulates Hippo Signaling Activity via Interactions with Large Tumor Suppressor Kinases
Xiao, L., Chen, Y., Ji, M., & Dong, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173468 · Cited by 190
Zhao, B., Kim, J., Ye, X., Lai, Z.-C., & Guan, K.-L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2997 · Cited by 192
Molecular insights into NF2/Merlin tumor suppressor function
Cooper, J., & Giancotti, F. G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.001 · Cited by 191
Fang, L., Teng, H., Wang, Y., Liao, G., Weng, L., Li, Y., Wang, X., Jin, J., Jiao, C., Chen, L., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.06.002 · Cited by 184
Ziosi, M., Baena-López, L. A., Grifoni, D., Froldi, F., Pession, A., Garoia, F., Trotta, V., Bellosta, P., Cavicchi, S., & Pession, A. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001140 · Cited by 184
“The atypical cadherins Fat (Ft) [26,32–37] and Dachsous (Ds) [20,26,33,38], as well as the FERM-domain proteins Expanded (Ex) and Merlin (Mer) [39], have also been implicated in the pathway as upstream components.”
BackgroundWang, K., Degerny, C., Xu, M., & Yang, X.-J. (2009) · Biochemistry and Cell Biology · doi:10.1139/o08-114 · Cited by 180
DNA binding partners of YAP/TAZ
Kim, M.-K., Jang, J.-W., & Bae, S.-C. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.3.015 · Cited by 181
Structural and functional analysis of the YAP-binding domain of human TEAD2
Tian, W., Yu, J., Tomchick, D. R., Pan, D., & Luo, X. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000293107 · Cited by 169
The Evolutionary History of YAP and the Hippo/YAP Pathway
Hilman, D., & Gat, U. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr065 · Cited by 166
“Previously, it has been suggested that the roots of the pathway may be represented by the mitotic exit network (MEN) and the separation initiation network pathways in the budding and fission yeast correspondingly (Bardin and Amon 2001; Harvey and Tapon 2007).”
BackgroundThe Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size
Watt, K. I., Turner, B. J., Hagg, A., Zhang, X., Davey, J. R., Qian, H., Beyer, C., Winbanks, C. E., Harvey, K. F., & Gregorevic, P. (2015) · Nature Communications · doi:10.1038/ncomms7048 · Cited by 164
Self-citationTAZ is a novel oncogene in non-small cell lung cancer
Zhou, Z., Hao, Y., Liu, N., Raptis, L., Tsao, M.-S., & Yang, X. (2011) · Oncogene · doi:10.1038/onc.2010.606 · Cited by 162
“Recently, TAZ has been identified as a component of an emerging Hippo-LATS tumor suppressor pathway that has important roles in regulating cell proliferation, apoptosis, tumor formation and organ size in both Drosophila and mammals (Harvey and Tapon, 2007; Saucedo and Edgar, 2007; Zhao et al., 2007, 2008; Zeng and Hon…”
BackgroundThe Hippo pathway and apico–basal cell polarity
Genevet, A., & Tapon, N. (2011) · Biochemical Journal · doi:10.1042/bj20110217 · Cited by 167
Self-citationHuang, W., Lv, X., Liu, C., Zha, Z., Zhang, H., Jiang, Y., Xiong, Y., Lei, Q.-Y., & Guan, K.-L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382036 · Cited by 159
Cdc14: a highly conserved family of phosphatases with non-conserved functions?
Mocciaro, A., & Schiebel, E. (2010) · Journal of Cell Science · doi:10.1242/jcs.074815 · Cited by 160
“Homologs of at least three Hippo pathway proteins are components of the MEN in S. cerevisiae and the SIN in S. pombe (Harvey and Tapon, 2007).”
BackgroundNPHP4, a cilia-associated protein, negatively regulates the Hippo pathway
Habbig, S., Bartram, M. P., Müller, R. U., Schwarz, R., Andriopoulos, N., Chen, S., Sägmüller, J. G., Hoehne, M., Burst, V., Liebau, M. C., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009069 · Cited by 162
“Several components of the pathway act as tumor suppressors or as protooncogenes (Harvey and Tapon, 2007).”
BackgroundCell Competition Drives the Growth of Intestinal Adenomas in Drosophila
Suijkerbuijk, S. J. E., Kolahgar, G., Kucinski, I., & Piddini, E. (2016) · Current Biology · doi:10.1016/j.cub.2015.12.043 · Cited by 160
“Relative Differences in Hippo Activity Determine the Cell Competition Potential of APC Cells The Hippo pathway plays an important role in growth control and can inhibitproliferationandpromoteapoptosis via inhibitoryphosphorylation of the downstream transcriptional co-activators YAP and TAZ (Yorkie [Yki] in Drosophila)…”
BackgroundStriedinger, K., VandenBerg, S. R., Baía, G. S., McDermott, M. W., Gutmann, D. H., & Lal, A. (2008) · Neoplasia · doi:10.1593/neo.08642 · Cited by 173
“regulate cell proliferation and apoptosis [16,17].”
BackgroundZhang, B., Shi, Y., Gong, A., Pan, Z., Shi, H., Yang, H., Fu, H., Yan, Y., Zhang, X., Wang, M., et al. (2016) · Stem Cells · doi:10.1002/stem.2432 · Cited by 156
TAZ Expression as a Prognostic Indicator in Colorectal Cancer
Yuen, H.-F., McCrudden, C. M., Huang, Y.-H., Tham, J. M., Zhang, X., Zeng, Q., Zhang, S.-D., & Hong, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054211 · Cited by 158
“TAZ and YAP have been shown to interact with several transcriptional factors [2,3,4], with the TEAD family of transcriptional factors (TEAD1-4) being the most relevant in cell proliferation and cancer progression [19,28,29].”
BackgroundInfluentialNi, L., Zheng, Y., Hara, M., Pan, D., & Luo, X. (2015) · Genes & Development · doi:10.1101/gad.264929.115 · Cited by 158
The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells
Zhou, D., Medoff, B. D., Chen, L., Li, L., Zhang, X.-F., Praskova, M., Liu, M., Landry, A., Blumberg, R. S., Boussiotis, V. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810773105 · Cited by 148
Modularity in the Hippo signaling pathway
Sudol, M., & Harvey, K. F. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.010 · Cited by 149
Self-citationZecca, M., & Struhl, G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000386 · Cited by 148
“Another system involved in growth is the evolutionarily conserved Warts-Hippo tumor suppressor pathway [9,10,11,12].”
BackgroundCancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice
Nishio, M., Hamada, K., Kawahara, K., Sasaki, M., Noguchi, F., Chiba, S., Mizuno, K., Suzuki, S. O., Dong, Y., Tokuda, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63735 · Cited by 149
“The evolutionarily conserved Hippo signaling pathway was first identified as regulating the cell proliferation and apoptosis-con-trolling organ size in Drosophila (6, 7).”
Salah, Z., Melino, G., & Aqeilan, R. I. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3516 · Cited by 150
“Many components of the Hippo pathway were discovered initially in Drosophila mosaic genetic screening owing to strong overgrowth phenotypes (3).”
BackgroundNf2/Merlin: a coordinator of receptor signalling and intercellular contact
Curto, M., & McClatchey, A. I. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604002 · Cited by 160
“…Research UK Keywords: Merlin; Ezrin; EGFR; contact-inhibition; adherens junctions; cytoskeleton All cancers result from the cumulative acquisition of molecular defects within a basic core of cellular functions that control proliferation, apoptosis, and invasiveness (Hanahan and Weinberg, 2000).”
BackgroundYap is a novel regulator of C2C12 myogenesis
Watt, K. I., Judson, R., Medlow, P., Reid, K., Kurth, T. B., Burniston, J. G., Ratkevicius, A., Bari, C. D., & Wackerhage, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.034 · Cited by 144
“controls events such as proliferation, apoptosis, differentiation, organ size and tumorigenesis in Drosophila melanogaster and some mammalian tissues [8,9].”
BackgroundLIM, C., NUNES, E. A., CURRIER, B. S., MCLEOD, J. C., THOMAS, A. C. Q., & PHILLIPS, S. M. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002929 · Cited by 142
“YAP and TAZ not only control cell growth in Drosophila melanogaster and somemammalian tissues (8,9) but also regulatemyoblast proliferation and differentiation (10,11).”
BackgroundIdentification of Driver and Passenger DNA Methylation in Cancer by Epigenomic Analysis
Kalari, S., & Pfeifer, G. P. (2010) · Advances in Genetics · doi:10.1016/b978-0-12-380866-0.60010-1 · Cited by 144
“The pathway consists of a kinase cascade including the Drosophila Hippo kinase orthologues MST1 and MST2 and the LATS/WARTS serine/threonine kinases as well as several adapter proteins including RASSF proteins, SAV1, and MOB1 (Guo et al., 2007; Harvey and Tapon, 2007).”
Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway
Li, Y., Zhou, H., Li, F., Chan, S. W., Lin, Z., Wei, Z., Yang, Z., Guo, F., Lim, C. J., Xing, W., et al. (2015) · Cell Research · doi:10.1038/cr.2015.69 · Cited by 140
Metadata
- Authors
- Harvey, K., & Tapon, N.
- Affiliations
- Peter MacCallum Cancer Centre (AU)
- Cancer Research UK (GB)
- Corresponding author
- Harvey, Kieran
- Venue
- Nature Reviews Cancer
- Published
- 2007-03
- Volume
- 7
- Issue
- 3
- Pages
- 182-191
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1567765448
- Cited by
- 628
- References
- 99
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 21 · 2023: 9 · 2022: 25 · 2021: 19 · 2020: 32 · 2019: 31 · 2018: 36 · 2017: 30 · 2016: 45 · 2015: 36 · 2014: 31 · 2013: 55 · 2012: 50
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- tumor suppression, tissue growth control, Drosophila melanogaster, carcinogenesis, evolutionary conservation, signaling networks, human cancer
- MeSH terms
- Hippo Kinases, Animals, Humans, Protein Kinases, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Drosophila Proteins, Intracellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.